Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The Investigational New Drug (IND) relates to a novel molecule targeting prostate cancer which will now progress towards the next stage of development, with clinical trials expected next year
read more
Monday, December 09, 2019
Jubilant Biosys announced commencement of two expansion projects in Greater Noida and Bengaluru.
read more
Tuesday, January 13, 2026
Jubilant Biosys Limited announced the opening of a new discovery and preclinical facility at Noida [Delhi NCR], doubling its overall chemistry capacity for discovery research and scale-up projects.
read more
Friday, February 15, 2019
Jubilant Biosys announced a new integrated drug discovery collaboration with Sanofi in the CNS therapeutic area.
read more
Jubilant Biosys and Collaborative Drug Discovery (CDD) announced Jubilant has chosen CDD Vault as their discovery research informatics platform for the next 5 years.
read more
Monday, September 19, 2016
Jubilant Biosys Ltd has announced two new leadership appointments. Mr. Steven Hutchins has been appointed as President and Dr. Takeshi Yura has been appointed as Vice President of Medicinal Chemistry.
read more
Jubilant Cadista Pharmaceuticals is voluntarily recalling one lot of Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg, 28x3 Blister Pack/Carton to the consumer level.
read more
Jubilant HollisterStier announced the appointment of Chris Preti as President. He brings more than 25 years of broad pharmaceutical industry experience to JHS.
read more
Jubilant Pharmova Limited has announced that Jubilant Pharma Limited, a wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, Jubilant HollisterStier LLC, (JHS) a leading US-based pharmaceutical contract manufacturer ...
read more
Friday, September 15, 2023
Jubilant HollisterStier Contract Manufacturing announced the appointment of Ian Fuller as the new Vice President of Operations.
read more
Wednesday, March 17, 2021
Jubilant Life Sciences has signed new contract with Eli Lilly for contract manufacturing of a treatment for COVID-19.
read more
Thursday, August 15, 2013
Jubilant HollisterStier announced today that the Montreal-based manufacturing facility has completed the first phase of an expansion of their sterile manufacturing capacity, with the addition of a new ampoule filling line utilizing a rigid barrier ...
read more
Wednesday, April 10, 2024
Univo IRB announced that Julie Blasingim has been promoted to CEO by Univo’s board of directors. As CEO, Blasingim will drive Univo IRB’s strategic growth and innovation, bringing a modern iteration of IRB solutions to unify patients and research, ...
read more
Wednesday, September 03, 2025
Julius Clinical, a clinical Contract Research Organization (CRO) with therapeutic expertise in CNS and Cardiometabolic indications, announced continued growth in bookings in these key therapeutic areas during the second quarter of 2025.
read more
Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc., has entered into a long-term collaboration with OxSonics Limited to support the development, scale-up, and GMP manufacturing of OxSonics' proprietary "sono-sensitive particles."
read more